Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nintedanib soft capsules 150 mg - UK EMC Drug Approval Details

Approvals/UK EMC/Nintedanib soft capsules 150 mg

Approved

STANDARD

Nintedanib soft capsules 150 mg

Eugia (UK) Limited🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: 8dc224d7224aebb2
Company: Eugia (UK) Limited
Type: Standard

Approval Details

Approval Id: 8dc224d7224aebb2
Drug Approval Emc Name: Nintedanib soft capsules 150 mg
Drug Name: Nintedanib soft capsules 150 mg
Company Name: Eugia (UK) Limited
Company Address: 1 Roundwood Avenue, Stockley Park, Uxbridge, UB11 1AF, UK
Company Website: www.eugiapharma.com
Company Telephone: +44 (0)208 845 8811
Company Fax: +44 (0)208 845 8795
Company Medical Info Direct Line: +44 (0)208 845 8811
Company Medical Info Email: [email protected]
Company Customer Care Direct Line: +44 (0)208 845 8811
Atc Code: L01EX09
Legal Category: Prescription only medicine

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

8dc224d7224aebb2

Type

Standard

Back to UK EMC Approvals